ReviewFrontiers in immunology2021

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.

Natasha Mupeta Kaweme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.